BlackRock Investment Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

BlackRock Investment Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.19M	Buy	21,410 +193	+0.9%	+$9.28K	﹤0.01%	2587
2016 Q3	$969K	Sell	21,217 -172	-0.8%	-$6.91K	﹤0.01%	2696
2016 Q2	$854K	Buy	21,389 +3,738	+21%	+$137K	﹤0.01%	2736
2016 Q1	$615K	Buy	17,651 +475	+3%	+$17.4K	﹤0.01%	2801
2015 Q4	$738K	Buy	17,176 +38	+0.2%	+$1.9K	﹤0.01%	2800
2015 Q3	$746K	Sell	17,138 -369	-2%	-$19.9K	﹤0.01%	2814
2015 Q2	$903K	Buy	17,507 +6,608	+61%	+$282K	﹤0.01%	2847
2015 Q1	$427K	Buy	10,899 +315	+3%	+$12.3K	﹤0.01%	3025
2014 Q4	$409K	Buy	10,584 +2	+0%	+$76	﹤0.01%	3096
2014 Q3	$374K	Buy	10,582 +477	+5%	+$14K	﹤0.01%	3114
2014 Q2	$272K	Buy	+10,105	New	+$263K	﹤0.01%	3206

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

BlackRock Investment Management's BSTC Position: Q4 2016 in Review

BlackRock Investment Management increased its BioSpecifics Technologies Corp. (BSTC) stake by 0.91% in Q4 2016, buying an estimated $9.28K and bringing the position to 21,410 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2587.

BlackRock Investment Management first reported a position in BSTC in Q2 2014 and has held it in 11 quarters since. 96 funds tracked by Wall St. Rank hold BSTC as of Q4 2016.

BlackRock Investment Management held 21,410 shares of BioSpecifics Technologies Corp. worth $1.19M as of Q4 2016.
BlackRock Investment Management bought 193 BioSpecifics Technologies Corp. shares in Q4 2016, an estimated $9.28K.
BioSpecifics Technologies Corp. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2587 holding.
BlackRock Investment Management first reported a position in BioSpecifics Technologies Corp. in Q2 2014 and has held it in 11 quarters since.
96 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.